Skip to main content

MoneyWorks4Me

USFDA completes audit at Dr. Reddy’s Laboratories’ Hyderabad plant

12 Jul 2019 Evaluate

US Food and Drug Administration (USFDA) has completed audit at Dr. Reddy’s Laboratories’ API Manufacturing Plant 2 at Bollaram, Hyderabad. The audit was completed on July 12, 2019. The company has been issued a Form 483 with 5 observations.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Peers
Company Name CMP
Sun Pharma. Inds. 1762.95
Dr. Reddys Labs. 1338.50
Cipla 1357.00
Lupin 1998.00
Zydus Lifesciences 1186.00
View more..